Breakthrough Pace Shows No Signs Of Slowing

FDA started off 2016 with a spate of new breakthrough therapy designations, feeding the popular program – and fueling agency concerns about workforce strain.

At least 11 new breakthrough therapy designations have been announced in the first seven weeks of 2016, as the expedited review program's popularity continues to rise at a fast pace.

The FDA Performance Tracker

More from Archive

More from Pink Sheet